Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

Just a few months after announcing a plan to separate its drug and cell therapy businesses into two separate companies, ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

Improving Global Access to Life-Changing Therapeutics... Following the successful Boston and London meetings, the ...

In the REAL8 basket trial, Sogroya (somapacitan), administered as a once-weekly subcutaneous injection, was at least as ...

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

President Donald Trump has signed an executive order that he claims will cut prescription drug prices supplied to the US to ...